The Department of Medicine

Rajiv Dhand, MD

Professor and Chair
Division of Pulmonary Medicine
Section of Critical Care Medicine

Education

Medical School
Postgraduate Institute, Chandigarh, India, 1978
National Board of Examinations (New Delhi, India) Degree in Respiratory Medicine, 1979

Residency
Postgraduate Institute, Chandigarh, India

Postgraduate School
Research Associate, Virginia Mason Research Center
Research Associate, University of Washington-Seattle, WA

Fellowship
Pulmonary, Postgraduate Institute, Chandigarh, India
Pulmonary & Critical Care Medicine, VA Medical Center, Boise, ID and University of Washington-Seattle, WA
Pulmonary & Critical Care Medicine, Loyola University Medical Center, IL

Certifications

Internal Medicine
Pulmonary Medicine
Critical Care Medicine

Professional Affiliations

Fellow, American College of Chest Physicians
Fellow, American College of Physicians
Fellow, American Association of Respiratory Care
Elected to America's Top Physicians

Books and Book Chapters

Dhand R. Inhaled Anticancer Agents. In: Advances in Pulmonary Drug Delivery. Boca Raton: CRC Press. Chapter 5, p. 67-92.

Current Publications

Dhand R, Mahler DA, Carlin B, Hanania N, Ohar J, Pinto-Plata V, Shah T, Eubanks D, Braman SS.
Results of a patient survey regarding COPD knowledge, treatment experiences, and practices with inhalation devices. Respiratory Care. 2018 Jul;63(7):833-839. Epub 2018 Mar 20.

Braman SS, Carlin BW, Hanania NA, Mahler DA, Ohar JA, Pinto-Plata V, Shah T, Eubanks D, Dhand R.
Results of a pulmonologist survey regarding knowledge and practices with inhalation devices for COPD. Respiratory Care. 2018 Jul;63(7):840-848. Epub 2018 May 1.

Dhand R.
The rationale and evidence for use of inhaled antibiotics to control pseudomonas aeruginosa infection in non-cystic fibrosis bronchiectasis. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2018 Jun;31(3):121-138. Epub 2017 Oct 27.

Dhand R, Cavanaugh T, Skolnik N.
COPD in primary care: Key considerations for optimized management: Considerations for optimal inhaler device selection in chronic obstructive pulmonary disease. The Journal of Family Practice. 2018 Feb;67(2 Suppl):S19-S27.

Dhand R, Cavanaugh T, Skolnik N.
Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease. Cleveland Clinic Journal of Medicine. 2018 Feb;85(2 Suppl 1):S19-S27.

Dhand R.
How should aerosols be delivered during invasive mechanical ventilation? Respiratory Care. 2017 Oct;62(10):1343-1367. Epub 2017 Sep 5.

Dhand R.
Inhaled drug therapy 2016: The year in review. Respiratory Care. 2017 Jul;62(7):978-996. Epub 2017 May 30.

Current Presentations

Baveja S, Akpa B, Ferris J, Amin S, McCormack M, Heidel E, Dhand R. A randomized, double dummy, crossover study comparing the bronchodilator effect of formoterol administered by nebulizer versus dry powder inhaler in patients recovering from severe exacerbations of chronic obstructive pulmonary disease. Presented at American Thoracic Society International Conference; 2018 May 18-23; San Diego, CA.

Dewald JB, Qiang H, Wyckoff K, Ferris J, Elder S, Dhand R. Bacterial contamination of nebulizers after a single in-hospital use. Presented at American Thoracic Society International Conference; 2018 May 18-23; San Diego, CA.

Akpa B, Baveja S, Reynolds B, Ferris J, Singh A, Hecht J, Dhand R. Clinical outcomes in patients who develop muscle weakness during an acute hospital stay. Presented at American Thoracic Society International Conference; 2018 May 18-23; San Diego, CA.

Reynolds BH, Martin E, Williams A, Akpa B, Ferris J, Heidel E, Baveja S, Dhand R. Do plasma levels of biomarkers reflect muscle injury in patients admitted to the floors in acute care hospitals? Presented at American Thoracic Society International Conference; 2018 May 18-23; San Diego, CA.

Akpa B, Baveja S, Blair R, Singh A, Ferris J, Hecht J, Dhand R. Incidence and clinical features of muscle weakness in patients admitted to a tertiary Medical Center. Presented at American Thoracic Society International Conference; 2018 May 18-23; San Diego, CA.

Dhand R. Advancement and understanding of pathogenesis and newer modalities of treatment for chronic obstructive pulmonary disease - bench to bedside. Presented at 21st Annual Thomas J. Godar Pulmonary/Critical Care Symposium (Invited Lecture); 2017 Sep 14; Hartford, CT.

Dhand R. Inhaled antibiotics. Presented at Bayer Amikacin Inhale Simulation Workshop (Invited Lecture); 2017 Aug 28-29; Hartford, CT.

Dhand R. How to write a scientific paper and get published. Presented at First Conference of Critical Care Medicine of Southern Medical University (Invited Lecture); 2017 Jun 17; Guangzhou, China.

Dhand R. A randomized, double-dummy, crossover study comparing the efficacy of nebulizers vs dry powder inhalers in patients recovering from severe exacerbations of COPD. Presented at 21st International Society for Aerosols in Medicine Congress (Invited Lecture); 2017 Jun 3-7; Santa Fe, NM.

Pinto-Plata V, Braman SS, Carlin B, Dhand R, Hanania N, Ohar J, Mahler DA, Eubanks D.. Are patients and physicians on the same page? Results of a survey regarding gaps in knowledge among patients with COPD and pulmonologists on nebulizer therapy. Presented at American Thoracic Society International Conference; 2017 May 19-24; Washington, DC.

Mahler D, Braman SS, Carlin B, Dhand R, Hanania N, Ohar J, Pinto-Plata V, Eubanks D.. Preference differences between patients and pulmonologists regarding inhalation devices for COPD. Presented at American Thoracic Society International Conference; 2017 May 19-24; Washington, DC.

Dhand R. The communication gap between patients with COPD and pulmonologists regarding inhalation delivery devices: Results from paired on-line surveys. Presented at American Thoracic Society International Conference; 2017 May 19-24; Washington, DC.

Dhand R. Evolution of nebulizers for inhalation therapy. Presented at Cipla India Ltd. (Invited Lecture); 2016 Dec 16; Mumbai, India.

Dhand R. Consensus towards use of nebulized antibiotics in clinical practice. Presented at Cipla India Ltd. (Invited Lecture); 2016 Dec 16; Mumbai, India.

Dhand R. New horizons: How should aerosols be delivered during mechanical ventilation? Presented at American Association for Respiratory Care Congress (Invited Lecture); 2016 Oct 15-16; San Antonio, TX.

Dhand R. Year in review: Aerosol therapy. Presented at American Association for Respiratory Care Congress (Invited Lecture); 2016 Oct 15-16; San Antonio, TX.

Gordon VHL, Dudney T, Dhand R, Shamiyeh J, Heidel RE. Total sleep time strongly correlate with self-reported hospital admissions: An inpatient COPD cohort survey. Presented at SLEEP; 2016 Jun 11-15; Denver, CO.

Braman S, Eubanks D, Carlin B, Dhand R, Hanania N, Mahler D, Ohar J, Pinto-Plata V, Shah T, Turenne M. Results of a pulmonologist survey regarding attitudes and practices with inhalation devices for COPD. Presented at American Thoracic Society International Conference; 2016 May 13-18; San Francisco, CA.

Wang H, Dhand R, Turner JF, McCormack MT, Chantal D, Church JD, Elder S. Comparison of aerosol delivery during simulated adult noninvasive positive pressure ventilation: Nebulizer versus pressurized metered-dose inhaler. Presented at American Thoracic Society International Conference; 2016 May 13-18; San Francisco, CA.